Related Experiment Video
Updated: Apr 17, 2026

10:56
A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
8.6K
[Homozygous familial hypercholesterolemia].
Summary
Familial hypercholesterolemia (FH) requires aggressive LDL-cholesterol reduction. New therapies targeting Apolipoprotein B offer hope for severe cases resistant to current treatments.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Pharmacology
Context:
- Familial hypercholesterolemia (FH) involves genetic LDL receptor defects, causing severe hypercholesterolemia and early atherosclerosis.
- Standard lipid-lowering therapies, including statins, are often insufficient for homozygous FH patients.
- LDL apheresis is effective but invasive, with compliance issues and residual atherosclerosis risk.
Purpose:
- To review emerging therapeutic strategies for Familial hypercholesterolemia.
- To discuss novel treatments targeting Apolipoprotein B (ApoB).
Summary:
- This review focuses on new treatments for FH, including Lomitapide (a MTTP inhibitor) and Mipomersen (an oligonucleotide).
- These agents target ApoB, offering potential efficacy even in receptor-negative homozygous FH patients.
- They address the unmet need for effective FH treatments beyond current modalities.
Impact:
- These novel ApoB-targeted therapies may significantly improve outcomes for severe FH patients.
- They represent a promising advancement in managing genetic dyslipidemias and preventing cardiovascular events.
- Successful implementation could reduce the burden of premature atherosclerosis in FH populations.
Related Concept Videos
Cholesterol: Significance and Regulation
2.0K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
2.0K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
801
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Genetic Lingo
118.9K
Overview
118.9K
Pharmacogenomics: Identification of New Drug Targets
95
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
95
Lipid Catabolism
1.4K
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
1.4K
Pleiotropy
44.3K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
44.3K

